Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2014. The report serves as a notification of transactions involving a person discharging managerial responsibility, specifically regarding changes in share interests.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The only material change disclosed is a transaction involving Mr. S M Bicknell, a person discharging managerial responsibility. On April 7, 2014, he purchased Ordinary Shares at a price of 1569.00 pence per share. This purchase resulted from the re-investment of dividends on shares held within an Individual Savings Account (ISA).
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The transaction was notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: April 7, 2014.
- Individual Involved: Mr. S M Bicknell (Person Discharging Managerial Responsibility).
- Transaction Type: Purchase of Ordinary Shares via dividend re-investment (ISA).
- Share Price: 1569.00 pence per Ordinary Share.
- Notification Date: April 8, 2014.